Rocket Doctor AI Inc. Announces Closing of Second Tranche of Oversubscribed Private Placement of Unsecured Convertible Debenture Financing

About this update from Rocket Doctor Ai Inc

Not for distribution to United States newswire services or for release publication, distribution, or dissemination directly, or indirectly, in whole or in part, in or into the United States Vancouver, British Columbia, Aug. 17, 2026 (GLOBE NEWSWIRE) -- Rocker Doctor AI Inc. (the "Company" or "Rocket Doctor AI") (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) is pleased to announce, further to its news release of July 28, 2026 and August 5, 2026, that it has closed the second tranche (the "Second Tranche") of its previously announced private placement (the "Offering") of unsecured convertible debentures (the "Debentures") for gross proceeds of C$992,000. Together with the closing of the first tranche of the Offering on August 5, 2026, the Company has raised aggregate gross proceeds of C$3,261,000.  The Debentures will bear interest from the date of issuance at a rate of 12.0% per annum, calculated and payable on maturity which is 12 months following the issuance of the Debentures (the "Maturity Date"). The principal amount of the Debentures, together with any accrued and unpaid interest, may be converted, in whole or in part at the election of the holder, into units of the Company (the "Units") at a conversion price of $0.70 (US$0.50) per Unit prior to or on the Maturity Date. Each Unit will consist of one common share in the capital of the Company (a "Share") and one transferable Share purchase warrant (a "Warrant"), with each Warrant being exercisable into one Share (a "Warrant Share") at an exercise price of $0.75 (US$0.54) per Warrant Share for a period of 12 months from the date of issuance (the "Warrant Expiry Date") pursuant to the terms therein.  The Warrant Expiry Date may be accelerated in the event the Shares trade on the CSE at $0.75 or more per Common Share for any 10 consecutive trading days, and, upon delivery of a notice to the holder, the Warrant Expiry Date will be accelerated to 5:00pm on the date that is 10 calendar days from the date of delivery of an acceleration notice to the holder. The Company intends on using the net proceeds of the Offering for working capital and general and administrative expenses, primarily focused on US growth plans.  "We are sincerely grateful to our investors for the strong support demonstrated through the closing of the second tranche of this oversubscribed financing," said Dr. Essam Hamza, CEO of R...

View stock analysis, news, and events for Rocket Doctor Ai Inc